Briefcases -- Drugs -- VALSARTAN MDL 2875 Products Liability Litigation USDC New Jersey

VALSARTAN MDL 2875 Products Liability Litigation USDC New Jersey

Case Files
News
Committees
Request a Document
Request
Search Within Briefcase

Folders

  1. JPML Initial Transfer and Consolidation Order
  2. Initial Case Filing Templates
    1. Master Long Form and Short Form Complaints
    2. Plaintiff Fact Sheet(s)
    3. Defendant Fact Sheet(s)
  3. Court Orders
    1. Pretrial Orders (PTOs)
    2. Case Management Orders (CMOs)
  4. Case Pleadings
  5. Bellwether Cases
  6. Evidentiary and Research Documents
    1. Single Event Case Filings
    2. Media References
    3. FDA Regulatory Materials
  7. Transcripts

Quick Access

  1. VALSARTAN MDL 2875 JPML Transfer Order (February 14, 2019)
  2. VALSARTAN Products Recall List (December 4, 2018)
  3. VALSARTAN (Selph) Complaint v Zhejiang Huahai Pharmaceutical Co., Ltd., et al., USDC WD of Arkansas (Fort Smith) (January 30, 2019)
  4. VALSARTAN (Roberts) Class-Action Complaint v. Zhejiang Huahai Pharmaceutical Co., Ltd., et al., USDC New Jersey (November 12, 2018)
  5. VALSARTAN (Jones) Complaint v. Zhejiang Huahai Pharmaceutical Co., Ltd., et al., USDC ED Missouri (Eastern) (September 11, 2018)
  6. VALSARTAN (Gremillion) Complaint v. Zhejiang Huahai Pharmaceutical Co., Ltd., et al., USDC WD of Louisiana (Lafayette) (November 15, 2018)
  7. More Blood Pressure Meds Recalled Due to Carcinogen by HealthDay News (December 7, 2018)
  8. FDA Warning Letter to Zheziang Huahai Pharmaceutical Co., Ltd. (November 29, 2018)